top of page
Cancer
Digest
Curated cancer news and information
Lung Cancer


Most non-small cell lung cancer patients treated with Keytruda® survive four or more years
Most patients with advanced non-small cell lung cancer treated with pembrolizumab were alive two years after discontinuing treatment without needing additional treatment, a new analysis has found.

Michael O'Leary


Sequential radiotherapy and immunotherapy boosts survival for non-small cell lung cancer patients
Non-small cell lung cancer patients survived longer when treated with a sequence of radiation and immunotherapy compared to being treated with the two at the same time, according to a new clinical trial.

Michael O'Leary


Severe lung infections may boost lung cancer risk
Image representing Covid lung infection generated by Wix AI CANCER DIGEST – March 16, 2026 – Scientists have discovered that serious viral lung infections that require hospitalization can alter immune cells in the lungs, leaving behind chronic inflammation that may help tumors develop months or years later, but that vaccination heads off those harmful effects. The study led by Jie Sun, PhD at the University of Virginia Health looked at the harmful effects of severe Covid-19 a

Michael O'Leary


Cancer treatments failing to consider older patients' preferences
A new large-scale analysis of older adults with advanced cancer reveals a stark "preference gap" in modern oncology, showing that clinical treatments rarely align with what patients actually value most.

Michael O'Leary


Durvalumab boosts survival for small-cell lung cancer but at a high cost
A new cost/benefit analysis of an immunotherapy drug that showed significantly longer survival for people with an aggressive form of lung cancer, called small-cell lung cancer, concludes that the treatment might be too expensive to be worth it.

Michael O'Leary


COVID-19 vaccine may have boosted survival in advanced lung cancer patients
Lung cancer patients who received COVID-19 vaccination survived nearly twice as long as similar patients who did not get the vaccine, a new observational study shows.

Michael O'Leary


A new injectable cancer drug may offer hope to people with recurrent head and neck cancer
A simple injection of a new type of drug may offer new hope for patients whose head an neck cancers returns after chemotherapy and immunotherapy, results of an ongoing early phase clinical trial show.

Michael O'Leary


Radiation may boost response in some immunotherapy resistant lung cancers
Clinical results suggest that radiation therapy might help overcome immunotherapy resistance in certain lung cancer patients

Michael O'Leary


Immunotherapy before and after surgery may open door to better outcomes for mesothelioma patients
Mesothelioma of the left lower lung on X-ray. Image by James Heilman, MD under Creative Commons license on Wikimedia CANCER DIGEST –...

Michael O'Leary


Targeted brain radiation may offer better outcomes for patients with metastasized small cell lung cancer
Image credit Mass General Brigham Hospital CANCER DIGEST – July 12, 2025 – Small cell lung cancer patients whose cancer has spread to the...

Michael O'Leary
bottom of page